PTGES3L is a chaperone-binding protein localized to the cytosol and nucleus that functions in protein folding and chaperone-mediated protein complex assembly, primarily through interactions with Hsp90 proteins [GO annotations]. While PTGES3L's canonical molecular function remains incompletely characterized, emerging evidence indicates disease relevance across multiple pathological contexts. In idiopathic inflammatory myopathies (IIMs), PTGES3L was identified as a skeletal muscle-specific candidate gene linked to type I interferon pathway activation through regulatory network analysis of rare genetic variants associated with disease susceptibility 1. PTGES3L has also been implicated as a downstream target gene in triple-negative breast cancer, where ZHX2-mediated transcriptional activation of PTGES3L contributes to HIF1α-driven oncogenic signaling and cell growth promotion 2. Additionally, PTGES3L variants showing cis-effects on gene expression were identified as potential causative factors in carotid paragangliomas 3. In drug-resistant tuberculosis, PTGES3L was identified as a component of an 8-gene host-derived transcriptional signature that discriminates DR-TB from drug-susceptible TB with high diagnostic accuracy (AUC=0.837), suggesting its role in host immune-metabolic dysfunction 4. These findings position PTGES3L as a multifunctional mediator in inflammatory, neoplastic, and infectious disease pathogenesis warranting further mechanistic investigation.